bioRxiv Science⌕ Search

Biology subjects

Sanchez Jimenez, A.

Publications and source records attributed to Sanchez Jimenez, A..

2 recordsLinked to original sources

Auditory midbrain encodes training-induced plasticity in soundlocalization behavior

The ability of the brain to learn from experience and to compensate for changes in sensory inputs is usually associated with plasticity in the cerebral cortex. Descending corticofugal pathways have been implicated in learning but there is limited evidence that subcortical processing is shaped by training. We show that sound-source location can be accurately decoded from neuronal populations recorded in the inferior colliculus of one or both hemispheres while ferrets perform a localization task. Furthermore, changes in neural decoding performance matched improvements in localization accuracy of individual animals when ferrets were trained to adapt to abnormal spatial cues resulting from reversible occlusion of one ear. These findings demonstrate that the activity patterns of populations of neurons in the inferior colliculus can account for sound localization behavior in different hearing contexts, and that training-dependent plasticity in the auditory midbrain may support spatial learning following monaural hearing loss.

neuroscience↗

Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants

The recent emergence of multiple SARS-CoV-2 variants has caused considerable concern due to reduced vaccine efficacy and escape from neutralizing antibody therapeutics. It is therefore paramount to develop therapeutic strategies that inhibit all known and future SARS-CoV-2 variants. Here we report that all SARS-CoV-2 variants analyzed, including variants of concern (VOC) Alpha, Beta, Gamma, and Delta, exhibit enhanced binding affinity to clinical grade and phase 2 tested recombinant human soluble ACE2 (APN01). Importantly, soluble ACE2 neutralized infection of VeroE6 cells and human lung epithelial cells by multiple VOC strains with markedly enhanced potency when compared to reference SARS-CoV-2 isolates. Effective inhibition of infections with SARS-CoV-2 variants was validated and confirmed in two independent laboratories. These data show that SARS-CoV-2 variants that have emerged around the world, including current VOC and several variants of interest, can be inhibited by soluble ACE2, providing proof of principle of a pan-SARS-CoV-2 therapeutic.

molecular biology↗